Clinical Trials on Alternative Medicines for COVID-19.
Stud Health Technol Inform
; 295: 366-369, 2022 Jun 29.
Article
in English
| MEDLINE | ID: covidwho-1924038
ABSTRACT
In this study, we addressed the alternative medications that have been targeted in the clinical trials (CTs) to be evidenced as an adjuvant treatment against COVID-19. Based on the outcomes from CTs, we found that dietary supplements such as Lactoferrin, and Probiotics (as SivoMixx) can play a role enhancing the immunity thus can be used as prophylactics against COVID-19 infection. Vitamin D was proven as an effective adjuvant treatment against COVID-19, while Vitamin C role is uncertain and needs more investigation. Herbals such as Guduchi Ghan Vati can be used as prophylactic, while Resveratrol can be used to reduce the hospitalization risk of COVID-19 patients. On the contrary, there were no clinical improvements demonstrated when using Cannabidiol. This study is a part of a two-phase research study. In the first phase, we gathered evidence-based information on alternative therapeutics for COVID-19 that are under CT. In the second phase, we plan to build a mobile health application that will provide evidence based alternative therapy information to health consumers.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Complementary Therapies
/
COVID-19 Drug Treatment
Type of study:
Prognostic study
/
Randomized controlled trials
Topics:
Traditional medicine
Limits:
Humans
Language:
English
Journal:
Stud Health Technol Inform
Journal subject:
Medical Informatics
/
Health Services Research
Year:
2022
Document Type:
Article
Affiliation country:
SHTI220740
Similar
MEDLINE
...
LILACS
LIS